The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
UAE condemns renewed Iranian attacks on Bahrain, Kuwait, Jordan and Iraq
Some UAE carriers extend flight suspensions to Kuwait, Bahrain
H.H. Sheikh Khaled witnesses launch of AED100 billion Marsa Al Saadiyat project
DP World, Fujairah Ports Authority sign 50-year deal for new Arabian Sea terminals
